Skip to main content

Table 1 Univariate analysis of participant characteristics in the functional constipation (FC) and non-FC groups, presented as the frequency or mean ± standard deviation (SD)

From: Background factors involved in the epidemiology of functional constipation in the Japanese population: a cross-sectional study

Items

FC (n = 262)

Non-FC (n = 2738)

P value*

Residential area: North (Tohoku, Hokkaido)/East (Kanto, Tokai, Koshinetsu)/West (Kinki, Chugoku, Shikoku, Kyushu), n/n/n

33/128/101

298/1483/959

0.250

Age, years (mean ± SD)

49.8 ± 13.1

45.8 ± 13.3

< 0.001**

Sex, female, n (%)

189 (72.1)

1308 (47.8)

< 0.001**

BMI, kg/m2 (mean ± SD)

21.0 ± 3.3

21.7 ± 3.6

0.002**

Jobs and education

 Employment status, n (%)

Student

10 (3.8%)

34 (1.2%)

0.360

Office worker

103 (39.3%)

1266 (46.2%)

0.030**

Self-employed

21 (8.0%)

216 (7.9%)

0.900

Part-time worker

36 (13.7%)

389 (14.2%)

0.930

Retired or unemployed

29 (11.1%)

439 (16.0%)

0.030**

Homemaker

72 (27.5%)

394 (14.4%)

< 0.001**

 Education, n (%)

Junior high school or high school

129 (49.2%)

1218 (44.5%)

0.150

Bachelor’s degree or higher

132 (50.4%)

1506 (55.0%)

0.150

Past history of disease

 Hypertension, n (%)

25 (9.5%)

377 (13.8%)

0.060

 Type 2 diabetes mellitus, n (%)

3 (1.1%)

196 (7.2%)

< 0.001**

 Hyperlipidemia, n (%)

25 (9.5%)

313 (11.4%)

0.410

 Lesion in the stomach, duodenum or small intestine, n (%)

0

291 (10.6%)

NA

 Inflammatory bowel disease, n (%)

0

0

 Hemorrhoids, n (%)

0

395 (14.4%)

NA

 Diverticulum, n (%)

0

35 (1.3%)

NA

 Gastrointestinal cancer, n (%)

0

0

 Cerebrovascular disease, n (%)

0

60 (2.2%)

NA

 Chronic obstructive pulmonary disease, n (%)

0

5 (0.2%)

NA

 Liver disease, n (%)

0

62 (2.3%)

NA

 Kidney disease, n (%)

0

62 (2.3%)

NA

 Abdominal surgery without appendectomy, n (%)

0

0

 Anemia, n (%)

36 (13.7%)

468 (17.1%)

0.190

Past treatment history

 Hypertensive drugs, n (%)

14 (5.3%)

276 (10.1%)

0.010**

 Insulin injections or Hyperglycemia drugs, n (%)

0

123 (4.5%)

NA

 Hyperlipidemia drugs, n (%)

22 (8.4%)

264 (9.6%)

0.580

 Cerebrovascular disease, n (%)

0

80 (2.9%)

NA

 Cardiovascular disease, n (%)

1 (0.4%)

81 (3.0%)

0.010**

 Chronic renal failure or history of dialysis, n (%)

0

26 (0.9%)

NA

 Depression or anxiety, n (%)

0

314 (11.5%)

NA

Lifestyle factors based on JHPI questionnaire

 Smoking more than 100 cigarettes per month and smoking for 6 month or longer, n (%)

41 (15.6%)

39 (1.4%)

0.580

 Alcohol drinking occasionally or daily, n (%)

156 (59.5%)

1046 (38.2%)

0.900

 Walking for 1 h/d, n (%)

100 (38.2%)

1027 (37.5%)

0.730

 Body weight gain of at least 10 kg, n (%)

45 (17.2%)

630 (23.0%)

0.036**

 Exercising for more than 30 min twice a week for at least 1 year, n (%)

57 (21.8%)

564 (20.6%)

0.630

 Walking or similar exercise for more than 1 h/d, n (%)

56 (21.4%)

567 (20.7%)

0.610

 Walking faster than other people of the same age, n (%)

97 (37.0%)

1038 (37.9%)

0.790

 Body weight gain or loss of at least 3 kg within 1 year, n (%)

86 (32.8%)

928 (33.9%)

0.780

 Eating faster than other people, n (%)

100 (38.2%)

1027 (37.5%)

0.730

 Having dinner within 2 h before going to sleep at least 3 times a week, n (%)

67 (25.6%)

794 (29.0%)

0.290

 Eating snacks after dinner at least 3 times a week, n (%)

83 (31.7%)

797 (29.1%)

0.390

 Skipping breakfast at least 3 times a week, n (%)

69 (26.3%)

715 (26.1%)

0.940

 Insufficient sleep, n (%)

144 (55.0%)

1588 (58.0%)

0.350

 Strong awareness of constipation, n (%)

71 (27.1%)

1171 (42.8%)

< 0.001**

Rome III criteria question items

 Improvement with defecation, n (%)

194 (74.0%)

1933 (70.6%)

0.255

 Onset associated with a change in frequency of stool, n (%)

133 (50.8%)

1613 (58.9%)

0.013**

 Onset associated with a change in form (appearance) of stool, n (%)

137 (52.3%)

1577 (57.6%)

0.103

 Straining during at least 25% of defecation, n (%)

211 (80.5%)

1828 (66.8%)

< 0.001**

 Lumpy or hard stool at least 25% of defecations, n (%)

210 (80.2%)

1682 (61.4%)

< 0.001**

 Sensation of incomplete evacuation for at least 25% of defecation, n (%)

230 (87.8%)

1828 (66.8%)

< 0.001**

 Sensation of hard evacuation, n (%)

255 (97.3%)

2036 (74.4%)

< 0.001**

 Manual maneuvers to facilitate digital evacuation at least 25% of defecation, n (%)

18 (6.9%)

144 (5.3%)

0.254

 Manual maneuvers to facilitate support of the pelvic floor at least 25% of defecation, n (%)

62 (23.7%)

321 (11.7%)

< 0.001**

 Loose stools are rarely present without the use of laxatives, n (%)

262 (100.0%)

843 (30.8%)

< 0.001**

Quality of life (SF-8)

 GH (mean ± SD)

46.9 ± 7.5

46.1 ± 7.8

0.121

 PF (mean ± SD)

47.2 ± 9.5

46.9 ± 9.0

0.532

 RP§ (mean ± SD)

48.6 ± 7.1

47.9 ± 7.9

0.158

 BP (mean ± SD)

48.5 ± 8.3

48.3 ± 8.6

0.655

 VT†† (mean ± SD)

48.1 ± 7.4

46.5 ± 7.9

0.002**

 SF‡‡ (mean ± SD)

47.9 ± 9.1

45.9 ± 10.2

0.002**

 MH§§ (mean ± SD)

48.9 ± 7.7

47.2 ± 8.3

0.001**

 RE¶¶ (mean ± SD)

45.0 ± 10.5

43.1 ± 10.9

0.010**

 PCS††† (mean ± SD)

46.9 ± 7.1

46.9 ± 7.5

0.966

 MCS‡‡‡ (mean ± SD)

46.7 ± 8.3

44.4 ± 9.2

< 0.001**

  1. *The level of significance is set at P < 0.05
  2. **Significant difference between groups
  3. GH general health, PF physical functioning, §RP role physical, BP body pain, ††VT vitality, ‡‡SF social functioning, §§MH mental health, ¶¶RE role emotional, †††PCS physical component summary, ‡‡‡MCS mental component summary